- Report
- August 2022
- 40 Pages
Brazil
From €1426EUR$1,500USD£1,200GBP
- Report
- August 2022
- 100 Pages
Global
From €2377EUR$2,500USD£2,000GBP
From €1426EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
United Kingdom
From €1426EUR$1,500USD£1,200GBP
- Report
- May 2022
- 40 Pages
United States
From €1426EUR$1,500USD£1,200GBP
- Drug Pipelines
- November 2020
- 52 Pages
Global
From €3328EUR$3,500USD£2,800GBP
- Report
- August 2023
- 1300 Pages
Global
From €8463EUR$8,900USD£7,120GBP
- Report
- August 2023
- 300 Pages
Middle East, Africa
From €4659EUR$4,900USD£3,920GBP
- Report
- August 2023
- 300 Pages
Latin America
From €4659EUR$4,900USD£3,920GBP
- Report
- August 2023
- 300 Pages
Asia Pacific
From €4659EUR$4,900USD£3,920GBP
- Report
- August 2023
- 300 Pages
Europe
From €4659EUR$4,900USD£3,920GBP
- Report
- August 2023
- 51 Pages
South Korea
From €571EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
India
From €571EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Mexico
From €571EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Australia
From €571EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Japan
From €571EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
United States
From €571EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Argentina
From €571EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Brazil
From €571EUR$600USD£480GBP
- Report
- August 2023
- 51 Pages
Italy
From €571EUR$600USD£480GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more